Clinical Trial Update: Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS) [Phase 2]

View source ↗

Summary

Phase 2 trial of eltrombopag with decitabine in advanced myelodysplastic syndrome has been terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Decitabine (Decitabine)
• Eltrombopag (eltrombopag)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2020-01-02